CoviRisk TBNK by Flow Cytometry - Blood

This test measures the levels of T cells, B cells, and natural killer (NK) cells in your blood.

• To assess the severity and prognosis of the SARS CoV 2 infection in hospitalised patients • To monitor the immune response during treatment for COVID-19 • To identify individuals with compromised immune function who may be at higher risk for severe illness • To guide appropriate interventions and therapies based on individual immune profiles

This test is recommended for • hospitalised patients with confirmed or suspected SARS CoV 2 infection, • individuals with persistent or worsening symptoms despite treatment, • patients with underlying health conditions that potentially affect immune function, or • individuals whose immune response needs to be assessed for targeted therapies or clinical trials.

Abnormal results may indicate an impaired immune response or excessive inflammation.

During this test, a small sample of your blood will be collected using a needle. The sample will be sent to the laboratory for analysis using flow cytometry.

• You can eat and drink normally and take your medications as prescribed. • Inform your doctor about any ongoing medications or medical conditions that may affect your immune system. Also, tell them if you have any specific requirements.

• RT-PCR or antigen tests for SARS CoV 2: to confirm the presence of the virus • Complete blood count (CBC): to evaluate overall blood cell counts and assess for any abnormalities • Other serological tests to measure specific antibodies against SARS CoV 2

SARS CoV 2 T-cell, B-cell, and natural killer cell count test

The severity and prognosis of SARS CoV 2 infection refer to the extent of illness and the likely outcome. Severe cases can lead to complications such as pneumonia, acute respiratory distress syndrome (ARDS), organ failure, and death. Prognosis varies based on individual factors such as age, overall health, and immune response.